News
Drug Development
FDA
Manufacturing
Deals
Business
Job Trends
Cell and Gene Therapy
Cancer
Opinions
Press Releases
All News & Releases
Podcasts
Events
Jobs
Companies
Hotbeds
More
Reports
Career Advice
NextGen: Top Startups to Watch
40 Under 40
Best Places to Work
Employer Resources
Advertise
Advertise
Talent Solutions
Post Jobs
Submit a Press Release
Submit an Event
SUBSCRIBE
Menu
SUBSCRIBE
Show Search
News
Drug Development
FDA
Manufacturing
Deals
Business
Job Trends
Cell and Gene Therapy
Cancer
Opinions
Press Releases
All News & Releases
Podcasts
Events
Jobs
Companies
Hotbeds
More
Reports
Career Advice
NextGen: Top Startups to Watch
40 Under 40
Best Places to Work
Employer Resources
Advertise
Advertise
Talent Solutions
Post Jobs
Submit a Press Release
Submit an Event
Search Query
Submit Search
Search Results
Submit
Looking for jobs?
Search jobs
Close
881,164 Results
Type
Article (88633)
Company Profile (817)
Press Release (791683)
Multimedia
Podcasts (230)
Webinars (34)
Section
Business (233528)
Career Advice (4159)
Deals (39956)
Drug Delivery (172)
Drug Development (91632)
Employer Resources (207)
FDA (18530)
Job Trends (17475)
News (398577)
Policy (40012)
Tag
2027 BioCapital Elite (1)
2027 BioMidwest Elite (2)
2027 Bio NC Standard (1)
2027 Biotech Bay Elite (1)
2027 Biotech Bay Standard (3)
2027 Biotech Beach Elite (2)
2027 Genetown Elite (4)
2027 Genetown Standard (3)
2027 Pharm Country Elite (2)
2027 Pharm Country Premier (1)
2027 Pharm Country Standard (5)
Academia (3045)
Academic (2)
Accelerated approval (50)
Adcomms (39)
Allergies (185)
Alliances (56987)
ALS (225)
Alzheimer's disease (1947)
Antibody-drug conjugate (ADC) (501)
Approvals (18820)
Artificial intelligence (821)
Autoimmune disease (320)
Automation (61)
Bankruptcy (407)
Best Places to Work (12635)
BIOSECURE Act (23)
Biosimilars (238)
Biotechnology (487)
Bladder cancer (203)
Brain cancer (81)
Breast cancer (798)
Cancer (6206)
Cardiovascular disease (529)
Career advice (3591)
Career pathing (49)
CAR-T (366)
CDC (75)
Celiac Disease (3)
Cell therapy (1025)
Cervical cancer (49)
Clinical research (78496)
Collaboration (2263)
Company closure (8)
Compensation (1440)
Complete response letters (103)
COVID-19 (3030)
CRISPR (119)
C-suite (1204)
Cystic fibrosis (164)
Data (8110)
Decentralized trials (3)
Denatured (87)
Depression (188)
Dermatology (89)
Diabetes (636)
Diagnostics (7519)
Digital health (61)
Diversity (13)
Diversity, equity & inclusion (49)
Drug discovery (397)
Drug pricing (244)
Drug shortages (39)
Duchenne muscular dystrophy (305)
Earnings (102402)
Editorial (77)
Employer branding (25)
Employer resources (174)
Events (137707)
Executive appointments (1162)
FDA (22426)
Fibrodysplasia Ossificans Progressiva (7)
Friedreich's ataxia (17)
Frontotemporal dementia (35)
Funding (1860)
Gene editing (263)
Generative AI (87)
Gene therapy (832)
GLP-1 (1249)
Government (5545)
Grass and pollen (8)
Guidances (413)
Healthcare (21099)
HIV (89)
Huntington's disease (62)
Idiopathic pulmonary fibrosis (2)
IgA nephropathy (102)
Immunology and inflammation (347)
Immuno-oncology (105)
Indications (194)
Infectious disease (3405)
Inflammatory bowel disease (240)
Inflation Reduction Act (17)
Influenza (147)
Intellectual property (300)
Interviews (820)
IPO (17992)
IRA (61)
Job creations (5206)
Job search strategy (2870)
JPM (73)
Kidney cancer (22)
Labor market (113)
Layoffs (680)
Leadership (50)
Legal (10171)
Liver cancer (108)
Longevity (35)
Lung cancer (811)
Lymphoma (440)
Machine learning (64)
Management (66)
Manufacturing (1154)
MASH (206)
Medical device (15234)
Medtech (15362)
Mergers & acquisitions (23222)
Metabolic disorders (1698)
mRNA (249)
Multiple sclerosis (197)
NASH (24)
Neurodegenerative disease (474)
Neuropsychiatric disorders (125)
Neuroscience (3602)
Neurotech (2)
NextGen: Class of 2026 (7713)
Non-profit (5137)
Now hiring (79)
Obesity (822)
Opinion (368)
Ovarian cancer (229)
Pain (275)
Pancreatic cancer (316)
Parkinson's disease (390)
Partnered (39)
Patents (626)
Patient recruitment (702)
Peanut (67)
People (67774)
Pharmaceutical (138)
Pharmacy benefit managers (36)
Phase 1 (24254)
Phase 2 (34100)
Phase 3 (25644)
Pipeline (8979)
Policy (387)
Postmarket research (3558)
Preclinical (10925)
Press Release (72)
Prostate cancer (321)
Psychedelics (68)
Radiopharmaceuticals (352)
Rare diseases (1205)
Real estate (7458)
Recruiting (81)
Regulatory (30120)
Reports (77)
Research institute (2763)
Resumes & cover letters (653)
Rett syndrome (40)
RNA editing (27)
RSV (98)
Schizophrenia (191)
Series A (315)
Series B (228)
Service/supplier (30)
Sickle cell disease (122)
Special edition (31)
Spinal muscular atrophy (189)
Sponsored (55)
Startups (4365)
State (2)
Stomach cancer (21)
Supply chain (139)
Tariffs (104)
The Weekly (140)
Vaccines (1267)
Venture capital (124)
Weight loss (568)
Women's health (132)
Worklife (24)
Date
Today (55)
Last 7 days (926)
Last 30 days (3608)
Last 365 days (32915)
2026 (13513)
2025 (33226)
2024 (38124)
2023 (42564)
2022 (53928)
2021 (58721)
2020 (57664)
2019 (51336)
2018 (39119)
2017 (37189)
2016 (38329)
2015 (44432)
2014 (39672)
2013 (36268)
2012 (38416)
2011 (38383)
2010 (39616)
Location
Africa (1296)
Alabama (102)
Alaska (7)
Arizona (391)
Arkansas (16)
Asia (52102)
Australia (9166)
California (13837)
Canada (3883)
China (1454)
Colorado (596)
Connecticut (614)
Delaware (424)
Europe (120134)
Florida (2049)
Georgia (451)
Hawaii (4)
Idaho (69)
Illinois (1179)
India (99)
Indiana (640)
Iowa (25)
Japan (557)
Kansas (141)
Kentucky (56)
Louisiana (46)
Maine (89)
Maryland (1690)
Massachusetts (10099)
Michigan (413)
Minnesota (770)
Mississippi (7)
Missouri (161)
Montana (37)
Nebraska (30)
Nevada (149)
New Hampshire (92)
New Jersey (3684)
New Mexico (34)
New York (3633)
North Carolina (1876)
North Dakota (11)
Northern California (6834)
Ohio (430)
Oklahoma (26)
Oregon (55)
Pennsylvania (2749)
Puerto Rico (30)
Rhode Island (53)
South America (1668)
South Carolina (87)
South Dakota (2)
Southern California (5414)
Tennessee (218)
Texas (2244)
United States (49561)
Utah (413)
Vermont (1)
Virginia (359)
Washington D.C. (88)
Washington State (1142)
West Virginia (4)
Wisconsin (153)
Wyoming (2)
There are 881,164 results that match your search.
Filters
Sort By
Relevance
Relevance
Newest
Oldest
Pancreatic cancer
Can Revolution’s ‘miracle’ pancreatic cancer drug be topped? Immuneering, Actuate say yes
Last month, Revolution Medicines’ RAS inhibitor doubled survival in a Phase 3 pancreatic cancer trial. On the biotech’s heels are Immuneering, Actuate Therapeutics, Erasca and more, looking to improve on that result with increased tolerability—and more time for patients.
May 18, 2026
·
7 min read
·
Heather McKenzie
Gene therapy
4 spaces primed for the next wave of gene therapies
The recent approval of Regeneron’s Otarmeni underscores the maturation of gene therapies across a range of diseases. Here,
BioSpace
reviews genetic medicines in development for the central nervous system, retinal, cardiac and neuromuscular diseases.
May 18, 2026
·
8 min read
·
Andrea Park
Opinion
FDA alignment is critical to serving the rare disease community. AI can help
The FDA has introduced models intended to accelerate rare disease drug development, but recent reversals of guidance from the agency speak to a lack of clarity in its implementation. AI can help focus this process.
May 18, 2026
·
4 min read
·
Rahul Gupta
Press Releases
United Therapeutics Corporation Announces ADVANCE OUTCOMES Study of Ralinepag Presented at ATS 2026
May 17, 2026
·
10 min read
Press Releases
Design Therapeutics to Host Investor Webcast to Review Data from RESTORE-FA Trial of DT-216P2 for Friedreich’s Ataxia on Monday, May 18, 2026
May 17, 2026
·
1 min read
Press Releases
New PSMAddition data show 58% lower risk of PSA progression with Pluvicto® in metastatic hormone-sensitive prostate cancer
May 17, 2026
·
8 min read
Press Releases
Nabsys Announces New OhmX Platform Installations Under Hitachi High-Tech America’s RAMP UP Program with Leading Cytogeneticist to Advance Applications in Hematologic Malignancies
May 17, 2026
·
7 min read
Press Releases
Nanobiotix Announces Presentation of Part 1 Data From a Randomized Phase 2 Clinical Trial Evaluating JNJ-1900 (NBTXR3) in Stage 3 Inoperable Lung Cancer
May 17, 2026
·
7 min read
Press Releases
New Real-World Case Series Examines Re-Induction with ADSTILADRIN® (nadofaragene firadenovec-vncg) in Clinical Practice
May 17, 2026
·
9 min read
Press Releases
Istituto Nazionale Tumori IRCCS Fondazione G. Pascale Selects MEVION S250-FIT™ for Southern Italy’s First Proton Therapy Center
May 17, 2026
·
5 min read
1 of 88,117
Next
